17,052
edits
Changes
Jump to navigation
Jump to search
Revise footnotes.
[[Image:Money.jpg|right|thumb|]]
The '''Financial Incentiveincentive''' to perform medically-unnecessary, non-therapeutic circumcision is very large. Circumcision, in the United States, is a multi-million billion dollar industry. Profit is reaped not only from the practice of circumcision itself, and associated hospital charges, but also from the sale of harvested foreskins, the sale of products derived from harvested foreskins, and the sale of circumcision specific tools and utensils, and the treatment of oomplications and botched circumcisions.
== The procedure itself ==
|accessdate=2019-10-23
|format=
|quote=As they saying goes, follow the money. Now you know why neither the [[American Academy of PediatriciansPediatrics]], American Medical Association, [[American Academy of Family Physicians]], or the [[American Congress of Obstetricians and Gynecologists| American College of Obstetricians and Gynecologists ]] haven’t condemned this unnecessary surgery, and why their physician members are quick to recommend the procedure to expectant parents.
}}</ref>
==Government support ==
Government medical insurance in the United States still holds the notion, which originated in the late 19th century, that the [[foreskin]] is a cesspool of disease, and circumcision improves hygiene and prevents sexually transmitted diseases (STDs), therefore it is best cut off and insurance should pay for it without any proof of medical indication or necessity, so there are no effective controls in force to see that only medically necessary services are covered.<ref name="hodges1997">{{REFbook |last=Hodges |first=Frederick |author-link=Frederick M. Hodges |last2= |first2= |author2-link= |year=1997 |title=A Short History of the Institutionalization of Involuntary Sexual Mutilation in the United States |url=https://link.springer.com/chapter/10.1007/978-1-4757-2679-4_2 |work=Sexual Mutilations: A Human Tragedy |editor=George C. Denniston, Marilyn Fayre Milos, Frederick Mansfield Hodges |edition= |volume= |chapter= |pages=17-40 |location= |publisher=Plenum Press |isbn= |quote= |accessdate=2020-08-04 |note=}}</ref>
===Medicaid===
While 18 states have stopped paying for it, 32 states still pay for non-therapeutic [[circumcision]]. Doctors may be driven to promote circumcision if they get a free stipend from the state.
The now expired AAP 2012 Policy Statement on Circumcision states stated that "Although health benefits are not great enough to recommend routine (i.e. non-therapeutic) circumcision for all male newborns, the benefits of circumcision are sufficient to justify access to this procedure for families choosing it and to '''warrant third-party payment''' for circumcision of male newborns. It is important that clinicians routinely inform parents of the health benefits and risks of male newborn circumcision in an unbiased and accurate manner." and "The American College of Obstetricians and Gynecologists has endorsed this statement."<ref>{{REFweb
|last=
|first=
===Tricare===
[https://www.tricare.mil/ Tricare] is the government medical insurance for military dependents. Tricare covers non-therapeutic circumcision of the newborn male infant.<ref>[https://www.tricare.mil/SearchResults?search=circumcisionCircumcision (Newborn)]</ref>
===Civil servants===
===Medicare===
The United States Medicare Program provides health insurance for persons who have reached the age of 65 years. It assumes that any man with a [[foreskin ]] needs a [[circumcision]]. It does not require proof of medical necessity. ===State and local government=== There are approximately 7,000,000 employees of state and local government. The great majority of these have health insurance that pays for non-therapeutic circumcision.
== Auxiliary tools ==
== Profit from harvested foreskins ==
Foreskins are sold to pharmaceutical companies for stem-cell research, the creation of synthetic skin, and the creation of consumer products. Since the 1980s, private hospitals have been involved in the business of supplying discarded foreskins to private bio-research laboratories and pharmaceutical companies who require human flesh as raw research material.<ref>A short history of the institutionalization of involuntary sexual mutilation in the United States. Hodges F. in: Denniston GC, Milos MF (eds). Sexual Mutilations: A Human Tragedy. New York: Plenum Press. 1997:17-40.<name="hodges1997" /ref> They also supply foreskins to transnational corporations. Dr. Tania Phillips, professor of dermatology at Boston University of Medicine, insisting foreskin gathering and cultivating is scientifically and technologically "very promising." <ref>Ronald Rosenberg. 19 October 1992: 22-23.</ref>
=== Corporate benefactors ===